An update of selective bladder preservation by combined modality therapy for invasive bladder cancer.
Shipley
W U
WU
Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.
Kaufman
D S
DS
Heney
N M
NM
Althausen
A F
AF
Zietman
A L
AL
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000401:mortality / Q000556:secondary / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D012074:Remission Induction; D015996:Survival Rate; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000628:therapy*